Home » Stocks » RAIN

Rain Therapeutics, Inc. (RAIN)

Rain Therapeutics will go public soon. The estimated IPO date is April 23, 2021.
Stock Price: $16.00 - $18.00
Current IPO price range
Market Cap 441.21M
Revenue (ttm) n/a
Net Income (ttm) -21.08M
Shares Out 25.95M
EPS (ttm) -0.81
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

Hide News

The news comes months after the company closed a $63 million Series B and inlicensed RAIN-32 from Daiichi Sankyo.

2 weeks ago - BioSpace

A fresh slate of biotech IPOs has filed to go public as the calendar turns toward the second quarter.

2 weeks ago - EndPoints News

Rain Therapeutics, Inc. has filed to go public with an IPO on the NASDAQ.

2 weeks ago - SEC

About RAIN

Rain Therapeutics is a clinical-stage precision oncology company developing therapies that target oncogenic drivers for which we are able to genetically select patients we believe will most likely benefit. This approach includes using a tumor-agnostic strategy to select patients based on their tumors’ underlying genetics rather than histology. We have in-licensed product candidates, each with a differentiated profile relative to available therapies, and we intend to continue strengthening our pipeline through focused business development and ... [Read more...]

Industry
Pharmaceutical Preparations
IPO Date
Apr 23, 2021
CEO
Avanish Vellanki
Employees
16
Stock Exchange
NASDAQ
Ticker Symbol
RAIN
Full Company Profile

Financial Performance

Financial Statements